BALYASNY ASSET MANAGEMENT L.P. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2023$537,332
+308.5%
193,285
+167.5%
0.00%
Q1 2023$131,524
-97.1%
72,266
-91.9%
0.00%
-100.0%
Q4 2022$4,547,593
+1810.8%
896,961
+1772.3%
0.01%
+1100.0%
Q3 2022$238,000
-1.7%
47,907
-26.2%
0.00%0.0%
Q2 2022$242,00064,9450.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 335,709$933,2710.26%
ALLEN HOLDING INC /NY 687,571$1,911,4470.26%
Clearwater Capital Advisors, LLC 394,599$1,096,9860.13%
SHEETS SMITH WEALTH MANAGEMENT 269,129$748,1790.11%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$268,0840.10%
WEALTH EFFECTS LLC 71,000$197,3800.09%
Virtus ETF Advisers LLC 37,888$105,3290.06%
DARK FOREST CAPITAL MANAGEMENT LP 203,659$566,1720.05%
Bell & Brown Wealth Advisors, LLC 20,100$55,8780.03%
FISHMAN JAY A LTD/MI 162,000$450,3600.03%
View complete list of IMMUNITYBIO INC shareholders